Skip to content

Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nominations of Todd Blanche, of Florida, to be Deputy Attorney General, and Abigail Slater, of

5 recorded connections shown. Select a record, office or person to follow its source references.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nominations of Todd Blanche, of Florida, to be Deputy Attorney General, and Abigail Slater, of

Hearings · Date not recorded

Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nominations of Todd Blanche, of Florida, to be Deputy Attorney General, and Abigail Slater, of: 5 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

The source did not record a date for this entry.

Jurisdiction code
US
Title
Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nominations of Todd Blanche, of Florida, to be Deputy Attorney General, and Abigail Slater, of
Starts at
2025-02-20T15:15:00+00:00
Location
Hart Senate Office Building, 216
Status
scheduled
Agenda url
https://www.congress.gov/event/119th-Congress/senate-event/336633